Call for Abstract
Scientific Program
31st Annual Congress on Vaccines, Clinical Trials & B2B, will be organized around the theme “Vaccines paradigms: Global resilience to Disease”
Vaccines & Clinical Trials 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Vaccines & Clinical Trials 2018
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Vaccine Immunoinformatics
- Track 1-2Research trends in development of Vaccines for Zika Virus
- Track 1-3Immunological challenges
- Track 1-4Vaccine Management & Quality Assurance
- Track 1-5Vaccines Research in USA
- Track 2-1Rotavirus Vaccine
- Track 2-2OPV Vaccine
- Track 2-3Smallpox Vaccine
- Track 2-4Rubella Vaccine
- Track 2-5Influenza vaccines
- Track 2-6Chickenpox Vaccine
- Track 2-7Cholera Vaccine
- Track 2-8Measles Vaccines
- Track 2-9Meningococcal /Menactra Vaccines
- Track 2-10Bordetella Vaccine
- Track 2-11Pneumonia Vaccines
- Track 2-12Zoster vaccine
- Track 3-1Childhood Travel Immunization
- Track 3-2Polio Vaccine
- Track 3-3Infant Immunization scheduling
- Track 3-4MMR vaccine
- Track 4-1Therapeutic cancer vaccines
- Track 4-2Feline Leukemia Vaccines
- Track 4-3Cervical Cancer Vaccine
- Track 4-4Gene-therapy
- Track 4-5Cancer Vaccines research
- Track 4-6Preventive cancer vaccines
- Track 5-1Live attenuated vaccines
- Track 5-2Preventive HIV Vaccines
- Track 5-3Recombinant sub-unit vaccines
- Track 5-4Peptide vaccines
- Track 5-5DNA Vaccines
- Track 5-6Emerging Clinical Trials
- Track 5-7T cell-based vaccines
- Track 5-8B cell-based vaccines
- Track 5-9Vaccines against viral toxins
- Track 6-1Modified live-virus vaccines for oral immunization of wildlife
- Track 6-2Vaccines for parenteral use
- Track 6-3Vaccines for Livestock Diseases
- Track 7-1TB vaccines
- Track 7-2Diphtheria vaccines
- Track 7-3Tetanus vaccines
- Track 7-4Pertussis vaccines
- Track 7-5Typhoid vaccines
- Track 7-6Cholera vaccines
- Track 8-1Mumps, measles and rubella/MMR Vaccines
- Track 8-2Live attenuated vaccines
- Track 8-3Rotavirus Vaccine
- Track 8-4Varicella (chickenpox) Vaccine
- Track 8-5Shingles Vaccine
- Track 8-6Yellow Fever Vaccine
- Track 8-7Adenovirus Oral Vaccine
- Track 8-8Vaccinia (Smallpox) Vaccine
- Track 9-1Vaccine safety communication
- Track 9-2HPV Vaccine safety and tolerability
- Track 9-3Post marketing surveillance of Vaccines
- Track 9-4Vaccine Pharmacovigilance
- Track 10-1Animal models in vaccine development
- Track 10-2Immune Cells responsiveness
- Track 10-3Clinical manifestation and IgE recognition
- Track 10-4Emerging clinical trials
- Track 11-1Advances in DNA Vaccines, TLRS and Combination Adjuvants
- Track 11-2Next-Generation Adjuvants
- Track 11-3Nanopatch Technologies
- Track 12-1Immunization and its side effects in geriatrics
- Track 12-2Vaccine dosing and administration in older adults
- Track 12-3Risk factors in geriatric immunization
- Track 13-1Clinical and Cellular Immunology
- Track 13-2Tumor and Cancer Immunology
- Track 13-3Neuro Immunology
- Track 13-4Autoimmunity and Therapathies
- Track 13-5Allergy & Asthma
- Track 13-6Antibodies and Bio Therapeutics
- Track 14-1Immunity to Infection
- Track 14-2Immunity to Bacteria & fungi
- Track 14-3Immunity to viruses
- Track 14-4Microbial Immunology
- Track 15-1Recombinant Vaccines
- Track 15-2Delivery methods
- Track 17-1Pre-clinical research
- Track 17-2Phases of Clinical trials
- Track 17-3Randomization Process
- Track 17-4Ethical Issues
- Track 17-5Clinical data management
- Track 17-6Post Marketing Surveillance
- Track 18-1Dermatology Clinical trials
- Track 18-2Clinical trials in Cardiology
- Track 18-3Clinical trials in Dementia
- Track 18-4Clinical Trials in Infections and Infectious Diseases
- Track 18-5Clinical Trials on Genetic Diseases
- Track 18-6Rare Diseases Clinical trials
- Track 18-7Clinical Trials in Respiratory Diseases
- Track 19-1Basic Design & Statistical concepts
- Track 19-2Design for Cancer clinical trials
- Track 19-3Efficacy & safety assessment
- Track 19-4Sequential Designs and concepts
- Track 20-1Case report form(CRF)
- Track 20-2CRF Development Process